Gilteritinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gilteritinib is used to treat a certain type of acute myeloid leukemia (AML) that has worsened or returned after treatment with other chemotherapy medications. Gilteritinib is in a class of medications called kinase inhibitors.Gilteritinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gilteritinib Nitroso Impurity 1 CAS NO:NA chemically represented as 6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-(nitroso(tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide. Synchemia is the leading manufacturing and exporter of Gilteritinib Nitroso Impurity 1 . We supply Gilteritinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144051 |
| CAS No | NA |
| Mol.F. | C18H20FN7O6 |
| Mol.Wt. | 449.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144052 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144053 |
| CAS No | NA |
| Mol.F. | C8H11N5O4 |
| Mol.Wt. | 241.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144054 |
| CAS No | NA |
| Mol.F. | C9H8FN3O3 |
| Mol.Wt. | 225.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144055 |
| CAS No | NA |
| Mol.F. | C17H18N4O7 |
| Mol.Wt. | 390.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144056 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144057 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144058 |
| CAS No | NA |
| Mol.F. | C23H22FN5O6 |
| Mol.Wt. | 483.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144059 |
| CAS No | NA |
| Mol.F. | C24H22FN9O8 |
| Mol.Wt. | 583.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144060 |
| CAS No | NA |
| Mol.F. | C6H9N3O5 |
| Mol.Wt. | 203.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144061 |
| CAS No | NA |
| Mol.F. | C7H13N3O5 |
| Mol.Wt. | 219.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144062 |
| CAS No | NA |
| Mol.F. | C3H5N3O5 |
| Mol.Wt. | 163.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144063 |
| CAS No | NA |
| Mol.F. | C16H19N5O4 |
| Mol.Wt. | 345.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |